News from Particle Sciences Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jul 28, 2016, 13:00 ET Eyeon Therapeutics Out-Licenses Proprietary OTC Dry Eye Product

Eyeon Therapeutics has licensed the North American rights to its patents and pending intellectual property for over-the-counter ophthalmic products...


Dec 01, 2015, 13:00 ET Patent Granted for Additional Polymer Technology Originated at Particle Sciences

 Eyeon Therapeutics has received a Notice of Allowance for additional novel dry eye treatments based on a charged hydrophilic polymer developed...


Sep 02, 2014, 11:40 ET Particle Sciences Expands Drug Eluting Device Capabilities and Overall Clinical Trial Manufacturing Resources

Particle Sciences, the leading CDMO for drug eluting devices, again adds to its investment in development and manufacturing capabilities with...


Jul 22, 2014, 11:20 ET Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology

 Eyeon Therapeutics has received a Notice of Allowance on a novel dry eye treatment based on a charged hydrophilic polymer developed at...


Jul 15, 2014, 11:00 ET Particle Sciences Expands Biopharmaceutical Development Infrastructure

Particle Sciences, Inc. has expanded its development capabilities to accommodate the increasing demand for biopharmaceutical formulation and...


Jun 09, 2014, 13:00 ET Microfluidics and Particle Sciences Align to Expand the Reach of Microfluidics Technology

Particle Sciences, Inc. and Microfluidics, a division of IDEX Corporation, are jointly working together to meet their Pharmaceutical client's need...


Apr 01, 2014, 11:00 ET Particle Sciences and Actavis Enter into Joint Development Agreement

 Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO), today announced that they have entered into an...


Nov 19, 2013, 10:30 ET BHR Pharma Engages Particle Sciences to Develop Nasal Progesterone for Traumatic Brain Injury

 Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO), has been contracted by BHR Pharma to develop an...


Oct 10, 2013, 13:05 ET Particle Sciences Completes Manufacture of New Vaginal Ring for HIV Prevention

 Particle Sciences, a drug delivery Contract Development and Manufacturing Organization (CDMO) , has completed the clinical trial...


Mar 05, 2013, 13:00 ET Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration

Particle Sciences, a leading drug delivery CRO, has teamed up with NETZSCH Premier Technologies, a leading manufacturer of wet milling and...


Nov 07, 2012, 13:05 ET Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics

 Particle Sciences, a leading drug delivery CRO, has developed a novel ocular formulation for its client, Eyeon Therapeutics, Inc.  The...


Oct 10, 2012, 13:05 ET Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF

 Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of an effort to create next generation...


Jun 06, 2012, 13:05 ET Particle Sciences Expands its cGMP Capabilities with the Addition of Thin Films

Particle Sciences, a leading drug delivery CRO, has added new coating capabilities for preparing polymer film-based drug products from liquid...


Feb 09, 2012, 13:05 ET CHEMO and Particle Sciences Partner to Provide the Only Development to Commercialization Solution for Hormone Eluting Drug/Device Combination Products

 Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, and CHEMO, a multinational and pharmaceutical company with strong industrial...


Jan 10, 2012, 13:30 ET Brabender® Pharma USA, Inc. and Particle Sciences Cooperate to Expand Extrusion Capabilities

 Particle Sciences Inc. (PSI), a leading pharmaceutical CRO is adding a Brabender® Mini-Compounder 12 mm twin screw extruder, plus an ATR...


Jan 03, 2012, 13:05 ET Particle Sciences Expands Its DOSE™ Program With Additional Proprietary Modeling Capabilities

 Particle Sciences, a leading drug delivery CRO, has added a third computational module to its DOSE™ program.  The DOSE™...


Oct 04, 2011, 13:05 ET Particle Sciences Granted Patent on Self Sterilizing Medical Devices

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, has received Notice of Allowance for a method of sterilizing medical devices.  The...


Jul 12, 2011, 13:00 ET Particle Sciences and Absorption Systems Form Relationship to Offer their Clients Enhanced Services

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, and Absorption Systems, a leading provider of pre-clinical pharmacokinetic services,...


Jun 22, 2011, 13:07 ET Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis' Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam)

In a recent announcement by Neurelis, a proprietary intranasal formulation of diazepam (NRL-1) achieved positive clinical results in a Phase I...


Apr 28, 2011, 13:05 ET Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO, and Celanese EVA Performance Polymers, a leading supplier of ethylene vinyl acetate...


Feb 07, 2011, 13:00 ET Particle Sciences and HORIBA Instruments Form Strategic Relationship

Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of...


Dec 22, 2010, 13:00 ET Particle Sciences Develops Wax Nanoparticles that Enhance Immune Response to Antigens

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO has formulated a series of wax nanoparticles that, when coupled with an antigen,...


Oct 19, 2010, 13:05 ET Particle Sciences and SoluBest Enter into Technology Agreement

Particle Sciences Inc. (PSI), a leading pharmaceutical CRO and SoluBest have entered into a licensing and technology development agreement....


Sep 07, 2010, 13:15 ET Children's Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts

Particle Sciences Inc. (PSI), a leading pharmaceutical Contract Research Organization (CRO), has been engaged by Children's Hospital Boston to help...


Jun 02, 2010, 13:05 ET Particle Sciences Adds Dried Blood Spot Analysis to its Bioanalytic Services

Particle Sciences has expanded its Bioanalytic Service's offerings to include Dried Blood Spot LC/MS/MS analysis (DBS).  DBS is a growing area...